Diametric Capital LP Purchases Shares of 95,161 Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Diametric Capital LP acquired a new stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) in the 4th quarter, Holdings Channel.com reports. The fund acquired 95,161 shares of the company’s stock, valued at approximately $217,000.

A number of other institutional investors have also recently made changes to their positions in STXS. Charles Schwab Investment Management Inc. boosted its stake in Stereotaxis by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after buying an additional 15,491 shares during the last quarter. State Street Corp boosted its position in shares of Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after acquiring an additional 36,518 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares in the last quarter. Barclays PLC increased its position in Stereotaxis by 449.9% in the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after purchasing an additional 83,412 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Stereotaxis by 7.2% during the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after purchasing an additional 93,253 shares in the last quarter. Hedge funds and other institutional investors own 45.35% of the company’s stock.

Insider Buying and Selling

In other news, Director Paul J. Isaac bought 38,000 shares of Stereotaxis stock in a transaction dated Monday, March 10th. The shares were acquired at an average price of $1.81 per share, with a total value of $68,780.00. Following the completion of the purchase, the director now owns 87,299 shares in the company, valued at $158,011.19. The trade was a 77.08 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. 18.52% of the stock is currently owned by company insiders.

Stereotaxis Stock Up 2.3 %

Shares of NYSEAMERICAN:STXS opened at $1.75 on Thursday. The business has a fifty day simple moving average of $2.12. Stereotaxis, Inc. has a 52 week low of $1.62 and a 52 week high of $3.29. The stock has a market cap of $148.28 million, a PE ratio of -6.25 and a beta of 1.54.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.